This Form 3 is a standard filing for a new insider and carries no trading signal. Monitor future filings for any open-market purchases or sales by the CEO, which would provide more actionable information on insider conviction.
Price Chart
Executive Summary
Jason Matuszewski, the CEO of BioStem Technologies, filed a Form 3 initial statement of beneficial ownership, disclosing his holdings of 1,278,433 common shares, options to buy 2,888,764 shares, and 522,529 restricted stock units. This is a routine regulatory filing required for new insiders and contains no material financial or operational information that would impact the stock price.
Key Facts
- Jason Matuszewski filed a Form 3 as the Chief Executive Officer of BioStem Technologies, Inc.
- Matuszewski directly owns 1,278,433 shares of common stock.
- He holds options to purchase 2,250,000 shares at $2.00 (expiring 2032-10-24), 198,807 shares at $10.05 (expiring 2035-03-17), 40,427 shares at $10.05 (expiring 2035-10-13), and 440,529 shares at $5.50 (expiring 2036-02-11).
- He holds 522,529 restricted stock units that convert to common stock on a 1:1 basis upon vesting.
- The filing is an initial ownership report, not a transaction, and contains no financial results, guidance, or corporate actions.
Financial Impact
No financial impact; this is a routine initial ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001634730-26-000004 |
| Document: 0001634730-26-000004-index.html | 0001634730-26-000004 |
| Document: 0001634730-26-000004.txt | 0001634730-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | EFFECT | $2.25 $2.11 | ▲ +6.22% | ▲ +5.14% | $1.48 (+34.22%) |
Oct 2, 2026 25d ago | S-1 | $2.76 $2.47 | ▲ +10.34% | ▲ +10.89% | $1.48 (+46.28%) |
Sep 30, 2026 27d ago | 8-K | $3.07 $2.73 | ▲ +11.07% | ▲ +11.81% | $1.48 (+51.79%) |
Sep 30, 2026 27d ago | EFFECT | $3.09 $3.07 | ▲ +0.65% | ▲ +0.83% | $1.48 (+52.10%) |
Sep 21, 2026 5w ago | Press Release | $3.98 $3.80 | ▼ −4.52% | ▼ −3.80% | $1.48 (−62.81%) |
Sep 18, 2026 5w ago | S-1 | $4.40 $3.98 | ▲ +9.55% | ▲ +9.53% | $1.48 (+66.36%) |
Sep 18, 2026 5w ago | Press Release | $4.74 $4.40 | ▲ +7.17% | ▲ +8.72% | $1.48 (+68.78%) |
Aug 14, 2026 10w ago | 3 | $3.00 $3.15 | ▲ +5.00% | ▲ +5.68% | $1.48 (−50.67%) |
Aug 14, 2026 10w ago | 3 | $3.00 $3.15 | ▲ +5.00% | ▲ +5.68% | $1.48 (−50.67%) |
Jul 29, 2026 12w ago | S-1 | $3.29 $3.20 | ▲ +2.74% | ▲ +4.41% | $1.48 (+55.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers